Concepedia

Brian Dreyfus

BD

8

Publications

229

Citations

8

H-Index

1983

Active since

Affiliations

Bristol-Myers Squibb (United States)(Current)

Boehringer Ingelheim (Germany)

Integrated Oncology (United States)

Johnson & Johnson (United States)

Sanofi (United States)

Brian Dreyfus is an author at Bristol-Myers Squibb (United States) specializing in radiation oncology, oncology, and medicine.

ORCID

Top concepts

Publications per year

1983–2023

8

Publications

8

Investigating Overlap in Signals from EVDAS, FAERS, and VigiBase®

Ulrich Vogel, John van Stekelenborg, Brian Dreyfus et al. · Drug Safety · 2020 · 64 citations · Full text

Predicting cardiac adverse events in patients receiving immune checkpoint inhibitors: a machine learning approach

Samuel P. Heilbroner, Reed Few, Tomas G. Neilan et al. · Journal for ImmunoTherapy of Cancer · 2021 · 44 citations · Full text

Early response to chemotherapy as a prognostic factor in Hodgkin's disease

Mathieu Kuentz, F Reyes, Bernard Brun et al. · Cancer · 1983 · 32 citations · Full text

5-Fluorouracil versus 5-fluorouracil plus α-interferon as treatment of metastatic colorectal carcinoma. A randomized study

P. Dufour, Fares Husseini, Brian Dreyfus et al. · Annals of Oncology · 1996 · 28 citations

, , +7

Selected adverse events in cancer patients treated with vascular endothelial growth factor inhibitors

Brian Dreyfus, Hugh Kawabata, Andres Gomez‐Caminero · Cancer Epidemiology · 2012 · 17 citations

, , +11

Rows per page

1–5 of 8